Tweet
Vaccine project shelved over production costs
Umesh Isalkar, TNN Jun 29, 2012, 12.41AM IST
PUNE: An ambitious plan to indigenously develop a vaccine against the deadly Crimean Congo Hemorrhagic Fever (CCHF) had to be shelved because the pharmaceutical companies did not find large-scale production of the vaccine economically viable.
Pune-based National Institute of Virology (NIV) had developed a candidate vaccine against the virus. But it had to shelve the project following pharmaceutical companies' dismal response, giving a setback to the country's plan to develop its own vaccine against the tick-borne disease.
...
Umesh Isalkar, TNN Jun 29, 2012, 12.41AM IST
PUNE: An ambitious plan to indigenously develop a vaccine against the deadly Crimean Congo Hemorrhagic Fever (CCHF) had to be shelved because the pharmaceutical companies did not find large-scale production of the vaccine economically viable.
Pune-based National Institute of Virology (NIV) had developed a candidate vaccine against the virus. But it had to shelve the project following pharmaceutical companies' dismal response, giving a setback to the country's plan to develop its own vaccine against the tick-borne disease.
...
